Evidence mapPaperPMID 31067747Full record

ReviewNutrients2019

Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?

Sam N Scott, Lorraine Anderson, James P Morton, Anton J M Wagenmakers, Michael C Riddell

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sam N ScottSchool of Kinesiology and Health Science, York University, Toronto, ON M3J 1P3, Canada. sam-scott@live.co.uk.ORCID 0000-0003-2342-9865
Lorraine AndersonIndependent Researcher, Toronto, ON M3J 1P3, Canada. lo.anderson16@gmail.com.
James P MortonResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK. j.p.morton@ljmu.ac.uk.
Anton J M WagenmakersResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK. a.j.wagenmakers@ljmu.ac.uk.ORCID 0000-0003-1916-3822
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, ON M3J 1P3, Canada. mriddell@yorku.ca.ORCID 0000-0001-6556-7559
Liverpool John Moores University · GBYork University · CASystems, Applications & Products in Data Processing (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Around 80% of individuals with Type 1 diabetes (T1D) in the United States do not achieve glycaemic targets and the prevalence of comorbidities suggests that novel therapeutic strategies, including lifestyle modification, are needed. Current nutrition guidelines suggest a flexible approach to carbohydrate intake matched with intensive insulin therapy. These guidelines are designed to facilitate greater freedom around nutritional choices but they may lead to higher caloric intakes and potentially unhealthy eating patterns that are contributing to the high prevalence of obesity and metabolic syndrome in people with T1D. Low carbohydrate diets (LCD; <130 g/day) may represent a means to improve glycaemic control and metabolic health in people with T1D. Regular recreational exercise or achieving a high level of athletic performance is important for many living with T1D. Research conducted on people without T1D suggests that training with reduced carbohydrate availability (often termed "train low") enhances metabolic adaptation compared to training with normal or high carbohydrate availability. However, these "train low" practices have not been tested in athletes with T1D. This review aims to investigate the known pros and cons of LCDs as a potentially effective, achievable, and safe therapy to improve glycaemic control and metabolic health in people with T1D. Secondly, we discuss the potential for low, restricted, or periodised carbohydrate diets in athletes with T1D.

Indexed as

Athletic PerformanceBlood GlucoseDiet, Carbohydrate-RestrictedDiabetes Mellitus, Type 1Dietary CarbohydratesHumansBlood GlucoseDietary Carbohydratescarbohydratecarbohydrate periodisationexercise trainingglycaemiahypoglycaemiainsulinlow carbohydrate diettrain lowtype 1 diabetesvery low carbohydrate diet

Identifiers

PMID31067747
PMCPMC6566372
OpenAlexW2944470366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.